Thursday, August 14, 2008

AstraZeneca - Crestor: making hay

The British drugmaker is going to jointly promote Crestor with Abbott Labs in the US, a noteworthy reversal of AstraZeneca’s solo strategy up until now.

More

2 comments:

Anonymous said...

In January of this year, AZ initiated the SATURN trial to compare Crestor with Lipitor.

Perhaps that is why the co-promotion was agreed upon with Abbott.

Anonymous said...

What do you do think is in it for Abbott? will this affect Simcor?